ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,767,000 | +117.9% | 72,500 | 0.0% | 0.65% | +29.8% |
| Q4 2018 | $811,000 | -91.8% | 72,500 | -91.4% | 0.50% | -89.2% |
| Q3 2018 | $9,844,000 | -15.5% | 844,500 | +21.6% | 4.68% | +4.6% |
| Q2 2018 | $11,647,000 | -16.1% | 694,500 | -18.4% | 4.47% | -17.5% |
| Q1 2018 | $13,888,000 | +127.2% | 851,500 | +78.3% | 5.42% | +151.4% |
| Q4 2017 | $6,112,000 | +100.8% | 477,500 | +92.9% | 2.16% | +81.9% |
| Q3 2017 | $3,044,000 | +13.5% | 247,500 | -22.8% | 1.18% | +16.3% |
| Q2 2017 | $2,681,000 | +286.9% | 320,744 | +313.9% | 1.02% | +284.5% |
| Q1 2017 | $693,000 | +21.4% | 77,500 | +19.2% | 0.26% | +3.1% |
| Q4 2016 | $571,000 | – | 65,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |